US 11904046
Hydrocortisone oral liquid formulations
granted A61KA61K31/573A61K47/10
Quick answer
US patent 11904046 (Hydrocortisone oral liquid formulations) held by Eton Pharmaceuticals, Inc. expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Eton Pharmaceuticals, Inc.
- Grant date
- Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/573, A61K47/10, A61K47/14, A61K47/183